Clinical Trial

Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 31, 2025 (before its estimated March 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized clinical trial will determine the treatment effect of colchicine (1.5 mg loading dose and 0.5 mg daily thereafter) for 6 weeks on microvascular coronary reperfusion and infarct size in patients with acute coronary syndrome.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-07-22; most recent amendment 2025-05-27.
Status change: Not Yet Recruiting → Recruiting 2022-09-08
Trial Details
NCT Number NCT05472337
Lead Sponsor Pontificia Universidad Catolica de Chile
Collaborators: Fondo Nacional de Desarrollo Científico y Tecnológico, Chile
Conditions Acute Coronary Syndrome
Enrollment 50 participants
Start Date 2022-08-01
Primary Completion 2026-03-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-31